Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Topoisomerase-DNA covalent complexes are druggable targets for novel inhibitors.
• Developing new antibacterial and anticancer agents is a significant area of research.

Purpose of the Study:

• To investigate the molecular features of the Escherichia coli topoisomerase I (EctopoI)-DNA covalent complex (EctopoIcc) for molecular simulations.
• To demonstrate the utility of this approach in developing new antibacterial drugs.

Main Methods:

• Virtual screening to identify a model small molecule (SM), NSC76027.
• Experimental examination of NSC76027's binding to EctopoI and inhibition of its relaxation activity.
• Molecular dynamics (MD) simulations to analyze the stability of EctopoIcc and the ternary complex.

Main Results:

• NSC76027 directly binds to EctopoI and inhibits its activity.
• MD simulations confirmed the formation of a stable ternary complex involving EctopoIcc and NSC76027.
• EctopoI serves as a model for studying protein-DNA covalent complexes.

Conclusions:

• The EctopoI-DNA covalent complex is a viable target for developing novel antibacterial agents.
• NSC76027 shows promise as a potential therapeutic agent targeting topoisomerase.
• Molecular simulations are valuable tools for understanding drug interactions with protein-DNA complexes.